Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.84% | 40.46 | 0.9% | $2323.99m | |
| JNJ | Johnson & Johnson | 0.66% | 149.12 | 0.7% | $1163.14m | |
| ABBV | AbbVie, Inc. | 0.20% | 105.20 | 1.9% | $1036.33m | |
| MRK | Merck & Co., Inc. | -0.16% | 81.70 | 0.7% | $708.08m | |
| BMY | Bristol-Myers Squibb Co. | -0.19% | 62.06 | 1.0% | $685.82m | |
| LLY | Eli Lilly & Co. | -0.22% | 144.84 | 1.1% | $659.48m | |
| AZN | AstraZeneca Plc | -1.27% | 52.71 | 1.2% | $365.44m | |
| TTNP | Titan Pharmaceuticals, Inc. | 3.13% | 3.62 | 0.6% | $286.38m | |
| GSK | GlaxoSmithKline Plc | -0.15% | 37.35 | 0.2% | $227.74m | |
| NVS | Novartis AG | -1.23% | 90.45 | 0.2% | $202.14m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 17.62% | 97.98 | 0.0% | $119.74m | |
| RGEN | Repligen Corp. | 0.44% | 187.83 | 7.1% | $98.17m | |
| NVO | Novo Nordisk A/S | -1.06% | 67.42 | 0.1% | $90.61m | |
| RPRX | Royalty Pharma Plc | 0.81% | 42.12 | 0.2% | $82.33m | |
| CVAC | CureVac NV | -0.17% | 102.49 | 0.0% | $71.66m |
Company Profile
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.